Respiratory Research Unit, Department of Respiratory Medicine, Hvidovre Hospital, Copenhagen University Hospital-Hvidovre, Kettegaard Alle 30, 2650, Hvidovre, Denmark.
Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Respir Res. 2021 Oct 20;22(1):269. doi: 10.1186/s12931-021-01864-z.
We aimed to explore long-term predictors of severe exacerbations and mortality in adults with well-characterised asthma.
Adults (aged ≥ 15) with an objectively verified diagnosis of asthma were recruited from a Danish respiratory outpatient clinic between 1974 and 1990. All individuals were followed in Danish registries for vital status, hospital admissions for asthma and cause of death until end of 2017. Predictors of exacerbations were obtained from a repeated measures model. Standardised mortality rates (SMR) for all-causes were compared with the Danish background population. Hazard ratios for mortality were obtained from a cox proportional hazards model in a two-step process.
At baseline, the cohort comprised 1071 patients (mean age 38, SD 16, 61% women), of whom 357 (33%) died during follow-up, with 93 (26%) dying from asthma (primary diagnosis). We found an SMR of 1.24 (95% CI 1.11-1.37, p < 0.001) for all-cause mortality. Baseline predictors for asthma-related death and repeated severe exacerbations were increasing age, ever smoker, FEV < 80% pred., high blood eosinophils, longer duration of symptoms and use of SABA > twice daily. Being non-atopic, having a positive histamine challenge test and symptoms more than twice a week were also predictors of repeated exacerbations.
Markers of poor asthma control, including high use of SABA, are predictors of long-term exacerbation rate and mortality over 30 years in patients with well-characterised asthma. Improving asthma control, including lung function and reducing use of reliever medication, is vital for improving the long-term outcome of asthma.
我们旨在探索特征明确的哮喘成人患者中严重恶化和死亡的长期预测因素。
1974 年至 1990 年间,从丹麦呼吸门诊招募了具有客观证实的哮喘诊断的成年人(年龄≥15 岁)。所有患者均在丹麦登记处跟踪其生存状态、因哮喘住院情况和死因,直至 2017 年底。通过重复测量模型获得恶化的预测因素。将所有原因的标准化死亡率(SMR)与丹麦背景人群进行比较。使用两步 Cox 比例风险模型获得死亡率的风险比。
在基线时,队列包括 1071 名患者(平均年龄 38 岁,标准差 16 岁,61%为女性),随访期间有 357 名(33%)死亡,其中 93 名(26%)死于哮喘(主要诊断)。我们发现所有原因死亡率的 SMR 为 1.24(95%CI 1.11-1.37,p<0.001)。哮喘相关死亡和反复严重恶化的基线预测因素为年龄增长、曾吸烟者、FEV<80%预测值、高血嗜酸性粒细胞计数、症状持续时间较长和每日使用 SABA>2 次。非特应性、组胺激发试验阳性和每周症状出现两次以上也是反复恶化的预测因素。
包括高剂量使用 SABA 在内的不良哮喘控制标志物,是特征明确的哮喘患者 30 多年来恶化率和死亡率的长期预测因素。改善哮喘控制,包括肺功能和减少缓解药物的使用,对改善哮喘的长期结局至关重要。